CXCL8 and cancer: Using modified Boyden chamber experiments, we showed as a proof-of-concept that VT treatment could limit TC diapedesis across dermal or lung HMVECs that had been activated by various cancer-associated cytokines including thrombin, VEGF, and IL-8.